hydroxyindoleacetic acid has been researched along with Gelineau Syndrome in 12 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have measured the concentrations of substance P, somatostatin, homovanillic acid (HVA), vanillyl mandelic acid (VMA) and 5-hydroxyindoleacetic acid (5-HIAA) in the cerebrospinal fluid (CSF) of six patients suffering from narcolepsy and 12 age- and gender-matched controls using high pressure liquid chromatography (HPLC) and radioimmunoassay (RIA)." | 7.69 | CSF substance P somatostatin and monoaminergic transmitter metabolites in patients with narcolepsy. ( Grauer, MT; Hamann, G; Isenberg, E; Schimrigk, K; Strittmatter, M, 1996) |
| "We have measured the concentrations of substance P, somatostatin, homovanillic acid (HVA), vanillyl mandelic acid (VMA) and 5-hydroxyindoleacetic acid (5-HIAA) in the cerebrospinal fluid (CSF) of six patients suffering from narcolepsy and 12 age- and gender-matched controls using high pressure liquid chromatography (HPLC) and radioimmunoassay (RIA)." | 3.69 | CSF substance P somatostatin and monoaminergic transmitter metabolites in patients with narcolepsy. ( Grauer, MT; Hamann, G; Isenberg, E; Schimrigk, K; Strittmatter, M, 1996) |
| "The other had the sole symptom of excessive daytime sleepiness, confirmed by sleep latency tests, which was unaccompanied by systemic illness." | 1.27 | Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia. ( Barchas, JD; Berger, PA; Faull, KF; Guilleminault, C, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (66.67) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faull, KF | 4 |
| Barchas, JD | 4 |
| Foutz, AS | 3 |
| Dement, WC | 5 |
| Holman, RB | 2 |
| Mefford, IN | 1 |
| Baker, TL | 1 |
| Boehme, R | 1 |
| Ciaranello, RD | 1 |
| Guilleminault, C | 3 |
| Berger, PA | 1 |
| Strittmatter, M | 1 |
| Isenberg, E | 1 |
| Grauer, MT | 1 |
| Hamann, G | 1 |
| Schimrigk, K | 1 |
| Nishino, S | 1 |
| Fujiki, N | 1 |
| Ripley, B | 1 |
| Sakurai, E | 1 |
| Kato, M | 1 |
| Watanabe, T | 1 |
| Mignot, E | 1 |
| Yanai, K | 1 |
| Phillips, R | 1 |
| Faull, K | 1 |
| Gilbert, JC | 1 |
| Willer, JC | 1 |
| Bernheim-Chatelain, C | 1 |
| Ecoffet, M | 1 |
| Jaillon, P | 1 |
| Siever, L | 1 |
| Kraemer, H | 1 |
| Sack, R | 1 |
| Angwin, P | 1 |
| Berger, P | 1 |
| Zarcone, V | 1 |
| Barchas, J | 1 |
| Brodie, HK | 1 |
| Kish, SJ | 1 |
| Mamelak, M | 1 |
| Slimovitch, C | 1 |
| Dixon, LM | 1 |
| Lewis, A | 1 |
| Shannak, K | 1 |
| DiStefano, L | 1 |
| Chang, LJ | 1 |
| Hornykiewicz, O | 1 |
| Miller, JD | 1 |
| Bowersox, SS | 1 |
| Thiemann, S | 1 |
| King, RJ | 1 |
12 other studies available for hydroxyindoleacetic acid and Gelineau Syndrome
| Article | Year |
|---|---|
Monoamine metabolite concentrations in the cerebrospinal fluid of normal and narcoleptic dogs.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Dogs; Homovanillic Acid; Humans; Hydroxyin | 1982 |
Narcolepsy: biogenic amine deficits in an animal model.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Disease Models, Animal; Dogs; Dopamine; Ep | 1983 |
Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Amino Acids; Disorders of Excessive Somnolence; Female; | 1983 |
CSF substance P somatostatin and monoaminergic transmitter metabolites in patients with narcolepsy.
Topics: Adult; Biogenic Monoamines; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middl | 1996 |
Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Chemistry; Cerebral Cortex; Chromatography, Hi | 2001 |
A syndrome of hypersomnia with automatic behavior.
Topics: Adult; Attention; Automatism; Circadian Rhythm; Electroencephalography; Homovanillic Acid; Humans; H | 1975 |
The concentrations of amine metabolites in cerebrospinal fluid from normal and narcoleptic dogs [proceedings].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dogs; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; | 1979 |
[Letter: Narcolepsy. Suppression of paradoxical sleep by L-dopa].
Topics: Catecholamines; Cyproterone; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levod | 1976 |
Gradients of biogenic amine metabolites in cerebrospinal fluid.
Topics: Alzheimer Disease; Amphetamine; Brain Diseases; Brain Neoplasms; Depression; Homovanillic Acid; Huma | 1975 |
Brain neurotransmitter changes in human narcolepsy.
Topics: Adult; Aged; Brain; Cadaver; Dopamine; Female; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydrox | 1992 |
CNS monoamines and their metabolites in canine narcolepsy: a replication study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Disease Models, Animal; Dogs; Dopamine; Hydroxyindol | 1990 |
Monoamine interactions in narcolepsy and hypersomnia: a preliminary report.
Topics: 3,4-Dihydroxyphenylacetic Acid; Biogenic Amines; Brain; Dopamine; Homovanillic Acid; Humans; Hydroxy | 1986 |